Dietary boron modifies the effects of vitamin D3 nutrition on indices of energy substrate utilization and mineral metabolism in the chick.
An experiment was designed to test part of the hypothesis that physiologic amounts of dietary boron enhance utilization of or, alternatively, compensate for, inadequate concentrations of active vitamin D metabolites to normalize energy substrate utilization and mineral metabolism. Day-old cockerel chicks were fed a ground corn, high-protein casein, corn oil-based diet (< or = 0.18 mg B/kg) supplemented with physiologic amounts of boron (as orthoboric acid) at 0 (non-PSB) or 1.4 (PSB) mg/kg and vitamin D3 (as vitamin D3 powder in corn endosperm carrier) at 3.13 (inadequate, IVD) or 15.6 (adequate, AVD) micrograms/kg. After 26 days, IVD decreased food consumption and plasma calcium concentrations and increased plasma concentrations of glucose, beta-hydroxybutyrate, triglycerides, triiodothyronine, cholesterol, and alkaline phosphatase activity. In the IVD chicks, PSB returned plasma glucose and triglycerides to concentrations exhibited by the AVD chicks and increased food consumption in both IVD and AVD chicks. Histologic findings suggested that PSB enhanced maturation of the growth plate. A ninefold increase in dietary boron yielded only a two-fold increase in plasma boron concentration and no increase in femur boron concentration, which suggests that boron is under homeostatic control. The findings suggest that boron acts on at least three separate metabolic sites because it compensates for perturbations in energy substrate utilization induced by vitamin D3 deficiency, enhances major mineral content in bone, and, independently of vitamin D3, enhances some indices of growth cartilage maturation.
Hunt
C D
CD
United States Department of Agriculture, Agricultural Research Service, Grand Forks Human Nutrition Research Center, North Dakota.
Herbel
J L
JL
Idso
J P
JP
D020155:3-Hydroxybutyric Acid; D000469:Alkaline Phosphatase / Q000097:blood; D000704:Analysis of Variance; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D015519:Bone Density / Q000187:drug effects*; D001842:Bone and Bones / Q000737:chemistry; D001895:Boron / Q000008:administration & dosage / Q000032:analysis / Q000097:blood / Q000494:pharmacology*; D002118:Calcium / Q000097:blood; D002645:Chickens; D002762:Cholecalciferol / Q000008:administration & dosage / Q000494:pharmacology*; D002784:Cholesterol / Q000097:blood; D004032:Diet; D004435:Eating / Q000187:drug effects; D004734:Energy Metabolism / Q000187:drug effects*; D006132:Growth Plate / Q000187:drug effects* / Q000254:growth & development; D006885:Hydroxybutyrates / Q000097:blood; D008297:Male; D011897:Random Allocation; D014280:Triglycerides / Q000097:blood; D014284:Triiodothyronine / Q000097:blood
D001786:Blood Glucose; D006885:Hydroxybutyrates; D014280:Triglycerides; D014284:Triiodothyronine; D002762:Cholecalciferol; D002784:Cholesterol; D000469:Alkaline Phosphatase; D001895:Boron; D002118:Calcium; D020155:3-Hydroxybutyric Acid